These observations are consistent with previous studies (Figs 1a and 2a) that indicated the simultaneous up-regulation of both β4 integrin and FAK and an interaction between β4 integrin and FAK that is significantly correlated to human malignant triple-negative breast cancer. The gene discussed is PTK2; the disease is triple-negative breast carcinoma.